 | • レポートコード：D005-11485 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、オピオイド作動薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。オピオイド作動薬の種類別市場規模（コデイン、フェンタニル、メペリジン、メタドン、モルヒネ、ヒドロコドン）、用途別市場規模（疼痛管理、咳治療、下痢治療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Purdue Pharma、Egalet Corporation、Janssen Pharmaceuticals, Inc、Titan pharmaceuticals、Mallinckrodt Pharmaceuticals、Boehringer Ingelheim、Allergan, Plc、Sun Pharmaceuticals、Sanofi、Endo Pharmaceuticals Inc.、Pfizer Inc ・地域別グローバル市場分析 2015年-2020年 ・オピオイド作動薬の北米市場（アメリカ、カナダ、メキシコ） ・オピオイド作動薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・オピオイド作動薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・オピオイド作動薬の南米市場（ブラジル、アルゼンチン） ・オピオイド作動薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：コデイン、フェンタニル、メペリジン、メタドン、モルヒネ、ヒドロコドン ・用途別分析：疼痛管理、咳治療、下痢治療 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Opioids Agonist Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 18590 million by 2025, from USD 16980 million in 2019.
The Opioids Agonist Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Opioids Agonist Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Opioids Agonist Drugs market has been segmented into
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
By Application, Opioids Agonist Drugs has been segmented into:
Pain Management
Cough Treatment
Diarrhea Treatment
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Opioids Agonist Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Opioids Agonist Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Opioids Agonist Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Opioids Agonist Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Opioids Agonist Drugs Market Share Analysis
Opioids Agonist Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Opioids Agonist Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Opioids Agonist Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Opioids Agonist Drugs are:
Purdue Pharma
Egalet Corporation
Janssen Pharmaceuticals, Inc
Titan pharmaceuticals
Mallinckrodt Pharmaceuticals
Boehringer Ingelheim
Allergan, Plc
Sun Pharmaceuticals
Sanofi
Endo Pharmaceuticals Inc.
Pfizer Inc
Among other players domestic and global, Opioids Agonist Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioids Agonist Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioids Agonist Drugs, with price, sales, revenue and global market share of Opioids Agonist Drugs in 2018 and 2019.
Chapter 3, the Opioids Agonist Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids Agonist Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Opioids Agonist Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Opioids Agonist Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Opioids Agonist Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Opioids Agonist Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Codeine
1.2.3 Fentanyl
1.2.4 Meperidine
1.2.5 Methadone
1.2.6 Morphine
1.2.7 Hydrocodone
1.3 Market Analysis by Application
1.3.1 Overview: Global Opioids Agonist Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pain Management
1.3.3 Cough Treatment
1.3.4 Diarrhea Treatment
1.4 Overview of Global Opioids Agonist Drugs Market
1.4.1 Global Opioids Agonist Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Purdue Pharma
2.1.1 Purdue Pharma Details
2.1.2 Purdue Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Purdue Pharma SWOT Analysis
2.1.4 Purdue Pharma Product and Services
2.1.5 Purdue Pharma Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Egalet Corporation
2.2.1 Egalet Corporation Details
2.2.2 Egalet Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Egalet Corporation SWOT Analysis
2.2.4 Egalet Corporation Product and Services
2.2.5 Egalet Corporation Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Janssen Pharmaceuticals, Inc
2.3.1 Janssen Pharmaceuticals, Inc Details
2.3.2 Janssen Pharmaceuticals, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Janssen Pharmaceuticals, Inc SWOT Analysis
2.3.4 Janssen Pharmaceuticals, Inc Product and Services
2.3.5 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Titan pharmaceuticals
2.4.1 Titan pharmaceuticals Details
2.4.2 Titan pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Titan pharmaceuticals SWOT Analysis
2.4.4 Titan pharmaceuticals Product and Services
2.4.5 Titan pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mallinckrodt Pharmaceuticals
2.5.1 Mallinckrodt Pharmaceuticals Details
2.5.2 Mallinckrodt Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mallinckrodt Pharmaceuticals SWOT Analysis
2.5.4 Mallinckrodt Pharmaceuticals Product and Services
2.5.5 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boehringer Ingelheim SWOT Analysis
2.6.4 Boehringer Ingelheim Product and Services
2.6.5 Boehringer Ingelheim Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Allergan, Plc
2.7.1 Allergan, Plc Details
2.7.2 Allergan, Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Allergan, Plc SWOT Analysis
2.7.4 Allergan, Plc Product and Services
2.7.5 Allergan, Plc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sun Pharmaceuticals
2.8.1 Sun Pharmaceuticals Details
2.8.2 Sun Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sun Pharmaceuticals SWOT Analysis
2.8.4 Sun Pharmaceuticals Product and Services
2.8.5 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sanofi SWOT Analysis
2.9.4 Sanofi Product and Services
2.9.5 Sanofi Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Endo Pharmaceuticals Inc.
2.10.1 Endo Pharmaceuticals Inc. Details
2.10.2 Endo Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Endo Pharmaceuticals Inc. SWOT Analysis
2.10.4 Endo Pharmaceuticals Inc. Product and Services
2.10.5 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Pfizer Inc
2.11.1 Pfizer Inc Details
2.11.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Pfizer Inc SWOT Analysis
2.11.4 Pfizer Inc Product and Services
2.11.5 Pfizer Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Opioids Agonist Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Opioids Agonist Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Opioids Agonist Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Opioids Agonist Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Opioids Agonist Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Opioids Agonist Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Opioids Agonist Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
4.5 South America Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Opioids Agonist Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Opioids Agonist Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Opioids Agonist Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Opioids Agonist Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Opioids Agonist Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Opioids Agonist Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
6.3 UK Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
6.4 France Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Opioids Agonist Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Opioids Agonist Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Opioids Agonist Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
7.5 India Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Opioids Agonist Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Opioids Agonist Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Opioids Agonist Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Opioids Agonist Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Opioids Agonist Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Opioids Agonist Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Opioids Agonist Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Opioids Agonist Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Opioids Agonist Drugs Price by Type (2015-2020)
11 Global Opioids Agonist Drugs Market Segment by Application
11.1 Global Opioids Agonist Drugs Sales Market Share by Application (2015-2020)
11.2 Global Opioids Agonist Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Opioids Agonist Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Opioids Agonist Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Opioids Agonist Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Opioids Agonist Drugs Market Forecast (2021-2025)
12.2.2 Europe Opioids Agonist Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Opioids Agonist Drugs Market Forecast (2021-2025)
12.2.4 South America Opioids Agonist Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Opioids Agonist Drugs Market Forecast (2021-2025)
12.3 Opioids Agonist Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Opioids Agonist Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Opioids Agonist Drugs Market Share Forecast by Type (2021-2025)
12.4 Opioids Agonist Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Opioids Agonist Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Opioids Agonist Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Opioids Agonist Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Opioids Agonist Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Opioids Agonist Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Purdue Pharma Opioids Agonist Drugs Major Business
Table 9. Purdue Pharma Opioids Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Purdue Pharma SWOT Analysis
Table 11. Purdue Pharma Opioids Agonist Drugs Product and Services
Table 12. Purdue Pharma Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Egalet Corporation Basic Information, Manufacturing Base and Competitors
Table 14. Egalet Corporation Opioids Agonist Drugs Major Business
Table 15. Egalet Corporation Opioids Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Egalet Corporation SWOT Analysis
Table 17. Egalet Corporation Opioids Agonist Drugs Product and Services
Table 18. Egalet Corporation Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Janssen Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 20. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Major Business
Table 21. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Janssen Pharmaceuticals, Inc SWOT Analysis
Table 23. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product and Services
Table 24. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Titan pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 26. Titan pharmaceuticals Opioids Agonist Drugs Major Business
Table 27. Titan pharmaceuticals Opioids Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Titan pharmaceuticals SWOT Analysis
Table 29. Titan pharmaceuticals Opioids Agonist Drugs Product and Services
Table 30. Titan pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Major Business
Table 33. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Mallinckrodt Pharmaceuticals SWOT Analysis
Table 35. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product and Services
Table 36. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 38. Boehringer Ingelheim Opioids Agonist Drugs Major Business
Table 39. Boehringer Ingelheim Opioids Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Boehringer Ingelheim SWOT Analysis
Table 41. Boehringer Ingelheim Opioids Agonist Drugs Product and Services
Table 42. Boehringer Ingelheim Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Allergan, Plc Basic Information, Manufacturing Base and Competitors
Table 44. Allergan, Plc Opioids Agonist Drugs Major Business
Table 45. Allergan, Plc Opioids Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Allergan, Plc SWOT Analysis
Table 47. Allergan, Plc Opioids Agonist Drugs Product and Services
Table 48. Allergan, Plc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 50. Sun Pharmaceuticals Opioids Agonist Drugs Major Business
Table 51. Sun Pharmaceuticals Opioids Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Sun Pharmaceuticals SWOT Analysis
Table 53. Sun Pharmaceuticals Opioids Agonist Drugs Product and Services
Table 54. Sun Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Sanofi Basic Information, Manufacturing Base and Competitors
Table 56. Sanofi Opioids Agonist Drugs Major Business
Table 57. Sanofi Opioids Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Sanofi SWOT Analysis
Table 59. Sanofi Opioids Agonist Drugs Product and Services
Table 60. Sanofi Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Endo Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Major Business
Table 63. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Endo Pharmaceuticals Inc. SWOT Analysis
Table 65. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product and Services
Table 66. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Inc Opioids Agonist Drugs Major Business
Table 69. Pfizer Inc Opioids Agonist Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Pfizer Inc SWOT Analysis
Table 71. Pfizer Inc Opioids Agonist Drugs Product and Services
Table 72. Pfizer Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Opioids Agonist Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global Opioids Agonist Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Opioids Agonist Drugs Sales by Regions (2015-2020) (K Units)
Table 76. Global Opioids Agonist Drugs Sales Market Share by Regions (2015-2020)
Table 77. Global Opioids Agonist Drugs Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Opioids Agonist Drugs Sales by Countries (2015-2020) (K Units)
Table 79. North America Opioids Agonist Drugs Sales Market Share by Countries (2015-2020)
Table 80. North America Opioids Agonist Drugs Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Opioids Agonist Drugs Revenue Market Share by Countries (2015-2020)
Table 82. Europe Opioids Agonist Drugs Sales by Countries (2015-2020) (K Units)
Table 83. Europe Opioids Agonist Drugs Sales Market Share by Countries (2015-2020)
Table 84. Europe Opioids Agonist Drugs Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Opioids Agonist Drugs Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific Opioids Agonist Drugs Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Opioids Agonist Drugs Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Opioids Agonist Drugs Sales by Countries (2015-2020) (K Units)
Table 89. South America Opioids Agonist Drugs Sales Market Share by Countries (2015-2020)
Table 90. South America Opioids Agonist Drugs Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Opioids Agonist Drugs Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Opioids Agonist Drugs Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Opioids Agonist Drugs Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Opioids Agonist Drugs Revenue Market Share by Countries (2015-2020)
Table 96. Global Opioids Agonist Drugs Sales by Type (2015-2020) (K Units)
Table 97. Global Opioids Agonist Drugs Sales Share by Type (2015-2020)
Table 98. Global Opioids Agonist Drugs Revenue by Type (2015-2020) (USD Million)
Table 99. Global Opioids Agonist Drugs Revenue Share by Type (2015-2020)
Table 100. Global Opioids Agonist Drugs Sales by Application (2015-2020) (K Units)
Table 101. Global Opioids Agonist Drugs Sales Share by Application (2015-2020)
Table 102. Global Opioids Agonist Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global Opioids Agonist Drugs Market Share Forecast by Regions (2021-2025)
Table 104. Global Opioids Agonist Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global Opioids Agonist Drugs Market Share Forecast by Type (2021-2025)
Table 106. Global Opioids Agonist Drugs Sales Forecast by Application (2021-2025)
Table 107. Global Opioids Agonist Drugs Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Opioids Agonist Drugs Picture
Figure 2. Global Sales Market Share of Opioids Agonist Drugs by Type in 2019
Figure 3. Codeine Picture
Figure 4. Fentanyl Picture
Figure 5. Meperidine Picture
Figure 6. Methadone Picture
Figure 7. Morphine Picture
Figure 8. Hydrocodone Picture
Figure 9. Opioids Agonist Drugs Sales Market Share by Application in 2018
Figure 10. Pain Management Picture
Figure 11. Cough Treatment Picture
Figure 12. Diarrhea Treatment Picture
Figure 13. Global Opioids Agonist Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Opioids Agonist Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Opioids Agonist Drugs Sales Market Share by Manufacturer in 2019
Figure 34. Global Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Opioids Agonist Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Opioids Agonist Drugs Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 39. Global Opioids Agonist Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Opioids Agonist Drugs Revenue Market Share by Regions (2015-2020)
Figure 41. Global Opioids Agonist Drugs Revenue Market Share by Regions in 2018
Figure 42. North America Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
Figure 43. Europe Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
Figure 45. South America Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Opioids Agonist Drugs Sales and Growth Rate (2015-2020)
Figure 47. North America Opioids Agonist Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Opioids Agonist Drugs Sales Market Share by Countries (2015-2020)
Figure 49. North America Opioids Agonist Drugs Sales Market Share by Countries in 2018
Figure 50. North America Opioids Agonist Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Opioids Agonist Drugs Revenue Market Share by Countries in 2018
Figure 52. United States Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Canada Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Mexico Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Europe Opioids Agonist Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Opioids Agonist Drugs Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Opioids Agonist Drugs Revenue Market Share by Countries in 2019
Figure 58. Germany Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. UK Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. France Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Russia Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Italy Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Asia-Pacific Opioids Agonist Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Opioids Agonist Drugs Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Opioids Agonist Drugs Revenue Market Share by Regions 2019
Figure 66. China Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Japan Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Korea Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. India Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Southeast Asia Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. South America Opioids Agonist Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Opioids Agonist Drugs Sales Market Share by Countries in 2019
Figure 73. South America Opioids Agonist Drugs Revenue Market Share by Countries in 2019
Figure 74. Brazil Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Middle East and Africa Opioids Agonist Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Opioids Agonist Drugs Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Egypt Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Turkey Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 83. South Africa Opioids Agonist Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Global Opioids Agonist Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 85. Global Opioids Agonist Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Opioids Agonist Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Europe Sales Opioids Agonist Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Asia-Pacific Sales Opioids Agonist Drugs Market Forecast (2021-2025) (K Units)
Figure 89. South America Sales Opioids Agonist Drugs Market Forecast (2021-2025) (K Units)
Figure 90. Middle East & Africa Sales Opioids Agonist Drugs Market Forecast (2021-2025) (K Units)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
オピオイドの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Opioids market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.4% in the forecast period of 2020 to 2025 and will expected to reach USD 16810 million by 2025, from USD 15260 million in 2019. The Opioids market report provides…- 下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 20…
- 卵巣がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ovarian Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ovarian Cancer…
- 肺炎治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pneumonia Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pneumonia Treatment…
- 鎮痛及び解熱薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pain and Fever Relief Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pain and Fever Re…